Bill Text: NH HB1501 | 2022 | Regular Session | Introduced
Bill Title: Relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Introduced - Dead) 2022-03-15 - Refer for Interim Study: Motion Adopted Voice Vote 03/15/2022 House Journal 6 [HB1501 Detail]
Download: New_Hampshire-2022-HB1501-Introduced.html
HB 1501-FN - AS INTRODUCED
2022 SESSION
22-2756
05/11
HOUSE BILL 1501-FN
AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.
SPONSORS: Rep. McBeath, Rock. 26; Rep. Van Houten, Hills. 45; Rep. Abel, Graf. 13
COMMITTEE: Commerce and Consumer Affairs
-----------------------------------------------------------------
ANALYSIS
This bill repeals a prospective modification of RSA 417-E:1, III(f), regarding insurance coverage for pediatric autoimmune neuropsychiatric disorders. In 2024, the phrase "when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician" would have been removed from the statute.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
22-2756
05/11
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Two
AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Repeal; Pediatric Autoimmune Neuropsychiatric Disorders. 2019, 277:3, relative to a modification of insurance coverage for pediatric autoimmune neuropsychiatric disorders effective July 1, 2024, is repealed.
2 Effective Date. This act shall take effect 60 days after its passage.
22-2756
11/23/21
HB 1501-FN- FISCAL NOTE
AS INTRODUCED
AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.
FISCAL IMPACT: [ X ] State [ X ] County [ X ] Local [ ] None
|
| |||
| Estimated Increase / (Decrease) | |||
STATE: | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
Appropriation | $0 | $0 | $0 | $0 |
Revenue | $0 | $0 | $0 | Indeterminable |
Expenditures | $0 | $0 | $0 | Indeterminable |
Funding Source: | [ X ] General [ ] Education [ X ] Highway [ X ] Other - Various Government Funds | |||
|
|
|
|
|
COUNTY: |
|
|
|
|
Revenue | $0 | $0 | $0 | $0 |
Expenditures | $0 | $0 | $0 | Indeterminable |
|
|
|
|
|
LOCAL: |
|
|
|
|
Revenue | $0 | $0 | $0 | $0 |
Expenditures | $0 | $0 | $0 | Indeterminable |
METHODOLOGY:
This bill repeals a prospective modification of RSA 417-E:1, III(f), regarding insurance coverage
for pediatric autoimmune neuropsychiatric disorders.
The Insurance Department states this bill repeals the repeal of existing legislation that would be effective on 7/1/2024 under current law. The existing law mandates coverage for pediatric autoimmune neuropsychiatric disorders. The law has been in effect for a short period and the Department has performed an analysis of claims. However, the diagnosis code (D89.98) is not specific to just this patient population and cannot be relied upon to accurately identify claim costs therefore the impact of eliminating the repeal on claim costs and the insurance premium tax cannot be determined. The Department noted the impact on claim costs would not necessarily inform the impact on premiums, or premium tax. Issuers and purchasers may respond with premium increases, product design changes and buy-downs.
AGENCIES CONTACTED:
Insurance Department
